MYX 0.66% $4.60 mayne pharma group limited

From Fairfax 'Business Day' TodayA bullish trading update from...

  1. 6,606 Posts.
    lightbulb Created with Sketch. 12
    From Fairfax 'Business Day' Today

    A bullish trading update from Mayne Pharma helped push the shares ahead a sharp 7.5 per cent to 79 cents, putting it within sight of its all-time high of 83.5 cents touched earlier in the year.
    Earlier today it flagged a December half net profit of between $8.2 and $8.4 million on revenue of $68 to $71 million.
    This is a reversal from the year earlier net loss of $4.3 million on revenue of just $27.4 million.
    Mayne Pharma has undergone a dramatic overhaul, with acquisitions and new drug roll-outs accounting for the growth.
    The solid first half performance puts earnings on track to meet the Wilson HTM forecast of a full-year net profit of $17.3 million.


 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.